Nicotine replacement therapy in smoking cessation

Thorax

Volumn 58, Issue 6, 2003, Pages 464-465

  Campbell, I ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINE GUM; PLACEBO;

CLINICAL TRIAL; DRUG CHOICE; DRUG EFFICACY; HUMAN; ISCHEMIC HEART DISEASE; NICOTINE REPLACEMENT THERAPY; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; WITHDRAWAL SYNDROME;

HOSPITALIZATION; HUMANS; NICOTINE; NICOTINIC AGONISTS; SMOKING CESSATION;

EID: 0037794429     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.58.6.464     Document Type: Review

References (40)

1. Raw M, Jarvis MJ, Feyerabend C, et al. Comparison of nicotine chewing-gum and psychological treatments for dependent smokers. BMJ 1980;281:481-4.
2. Jarvis MJ, Raw M, Russell MAH, et al. Randomised, controlled trial of nicotine chewing-gum. BMJ 1982;285:537-40.
3. Hjalmarson AIM. Effect of nicotine chewing gum in smoking cessation: a randomised, placebo-controlled, double-blind study. JAMA 1984;252:283-8.
4. Sutherland G, Stapleton JA, Russell MAH, et al. Randomised, controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992;340:324-9.
5. Okuyemi KS, Jasjit SA, Harris KJ. Pharmacotherapy of smoking cessation. Arch Fam Med 2000;9:270-81.
6. Tonnesen P, Norregard J, Simonsen K, et al. A double-blind trial of a 16 hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991;325:311-5.
7. Westman EC, Levin ED, Rose JE. The nicotine patch in smoking cessation - a randomised trial with telephone counselling. Arch Intern Med 1993;153:1917-23.
8. Tonnesen P, Paoletti P, Gustavsson G, et al, on behalf of the European Respiratory Society. Higher dosage nicotine patches increase 1-year smoking cessation rates: results from the European CEASE trial. Eur Respir J 1999;13:238-46.
9. Imperial Cancer Research Fund General Practice Research Group. Effectiveness of the nicotine patch in helping people stop smoking: results of a randomised trial in general practice. BMJ 1993;306:1304-8.
10. Russell MAH, Stapleton JA, Feyerabend C, et al. Targeting heavy smokers in general practice: a randomised, controlled trial of transdermal nicotine patches. BMJ 1993;306:1308-12.
11. Jamrozik K, Fowler G, Vessey M, et al. Placebo controlled trial of nicotine chewing gum in general practice. BMJ 1984;289:794-7.
12. Marshall A, Raw M. Nicotine chewing gum in general practice: effect of follow-up appointment. BMJ 1985;290:1397-8.
13. Campbell I A, Lyons E, Prescott RJ. Stopping smoking: do nicotine chewing-gum and postal encouragement add to doctors' advice? Practitioner 1987;231:114-7.
14. Richmond RL, Makinson RJ, Keyhoe LA, et al. One-year evaluation of three smoking cessation interventions administered by general practitioners. Addict Behav 1993;18:187-99.
15. Russell MAH, Merriman R, Stapleton J, et al. Effect of nicotine chewing gum as an adjunct to general practitioners' advice against smoking. BMJ 1983;287:1782-5.
16. Tonnessen P, Norregaard J, Mikkelsen K, et al. A double-blind trial of a nicotine inhaler in smoking cessation. JAMA 1993;269:1268-71.
17. Hjalmarson A, Nilsson F, Sjostrom L, et al. The nicotine inhaler in smoking cessation. Arch Intern Med 1997;157:1721-8.
18. Hjarmarson A, Franzom M, Westin A, et al. Effect of nicotine nasal spray on smoking cessation: a randomised, placebo controlled double-blind study. Arch Intern Med 1994;154:2567-72.
19. Schneider NG, Olmstead R, Mody FV, et al. Efficiency of a nicotine nasal spray in smoking cessation: a placeo-controlled, double-blind trial. Addiction 1995;90:1671-82.
20. Shiffman S, Dresler CM, Hajek P, et al. Efficacy of a nicotine lozenge for smoking. Arch Intern Med 2002;162:1267-76.
21. Tonnessen P, Mikkelsen KL. Smoking cessation with four nicotine replacement regimes in a lung clinic. Eur Respir J 2000;16:717-22.
22. Blondal T, Franz M, Westin A. A double-blind trial of nicotine nasal spray as an aid in smoking cessation. Eur Respir J 1997;10:185-90.
23. Wallstrom M, Nilson F, Hirsch JM. A randomised double-blind, placebo-controlled clinical evaluation of a nicotine sub-lingual tablet in smoking cessation. Addiction 2000;95:1161-71.
24. Kornitzer M, Boutsen M, Dramaix M, et al. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 1995;24:41-7.
25. Puska P, Korhonen HJ, Vartiainen E, et al. Combined use of nicotine patch and gum compared with gum alone in smoking cessation: a clinical trial in North Karelia. Tobacco Control 1995;4:231-5.
26. Hajek P, West R, Foulds J, et al. Randomised comparative trial of nicotine polacrilex, a transdermal patch, nasal spray and an inhaler. Arch Intern Med 1999;159:2033-8.
27. Blondal T, Gudmundsson LJ, Olafsdottir I, et al. Nicotine nasal spray or nicotine patch for smoking cessation: randomised trial with six year follow-up. BMJ 1999;318:285-9.
28. Jorenby DE, Smith SS, Fiore MC, et al. Varying nicotine patch dose and type of smoking cessation counselling. JAMA 1995;274:1347-52.
29. Fiore MC, Smith SS, Jorenby DE, et al. The effectiveness of nicotine patch for smoking cessation. JAMA 1994;271:1940-7.
30. Silagy C, Lancaster T, Stead L, et al. Nicotine replacement therapy for smoking cessation (Cochrane Review). In: The Cochrane Library. Issue 4. Oxford: Update Software, 2002: 13.
31. US Department of Health and Social Services. The health consequences of smoking: nicotine addiction: a report of the Surgeon General. DHHS publication (CDC) 88-406, Atlanta, GA: Centres for Diseases Control, Office on Smoking and Health, 1998.
32. Hughes JR, Gust SW, Keenan R, et al. Long term use of nicotine vs placebo gum. Arch Intern Med 1991;151:1993-8.
33. Fiore MC, Jorenby DE, Baker TB, et al. Tobacco dependence and nicotine patch: clinical guidelines for effective use. JAMA 1992;268:2687-94.
34. British Thoracic Society. Comparison of four methods of smoking withdrawal in patients with smoking-related diseases. BMJ 1993;286:595-7.
35. Molyneux A, Lewis S, Leivers U, et al. Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients. Thorax 2003;58:484-8.
36. Campbell I A, Prescott RJ, Tjeder-Burton SM. Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: placebo-controlled study. Respir Med 1996;90:47-51.
37. Campbell IA, Tjeder-Burton SM, Prescott RJ. Smoking cessation in hospital patients given repeated advice plus nicotine or placebo chewing gum. Respir Med 1991;85:155-7.
38. Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996;335:1792-8.
39. Hand S, Edwards S, Campbell IA, et al. Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support. Thorax 2002;57:715-8.
40. National Institute for Clinical Excellence (NICE). Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. Technology Appraisal Guidance No 39. London: NICE, March 2002.